Ireland· IE-PA-EU/1/21/1537/001-004
NEXPOVIO 20 mg film-coated tablets
A selinexor product containing selinexor, registered in Ireland by Karyopharm Europe GmbH. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Selinexor is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XX66 (selinexor), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Selinexor · ATC L01XX66
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of selinexor costs, country by country.
Normalised to the WHO defined daily dose (18.6 mg), the median price runs from $0.99 in France to $402.73 in Switzerland — a ×406 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Selinexor · price per daily dose (18.6 mg)
USD · FX 28 Sept 2026
- CH Switzerland$402.73
- FR France$0.99
The record
At a glance
HPRA (Ireland)- Active substance
- Selinexor
- Manufacturer
- Karyopharm Europe GmbH
- Country
- Ireland (IE)
- ATC code
- L01XX66
- ATC class
- Selinexor
- Defined daily dose
- 18.6 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/21/1537/001-004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
72 interactions on record for selinexor.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Selinexor · interactions on record
72 records
- 29 severe
- 43 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Selinexor in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandNexpovio 20 mg, FilmtablettenStemline Therapeutics Switzerland GmbH
- CzechiaNEXPOVIOStemline Therapeutics B.V., Amsterdam
- FinlandNEXPOVIOStemline Therapeutics B.V.
- FranceNEXPOVIO 20 mg, comprimé pelliculéSTEMLINE THERAPEUTICS (PAYS-BAS)
- IcelandNEXPOVIOStemline Therapeutics B.V.
- NetherlandsNEXPOVIO 20 mg, filmomhulde tabletStemline Therapeutics B.V.
- PolandNEXPOVIOStemline Therapeutics B.V.
- SwedenNEXPOVIO 20 mg Filmdragerad tablettStemline Therapeutics B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nexpovio
- Liechtenstein · Nexpovio
- Norway · Nexpovio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef921ef1-53c3-4a71-924a-e0ec77d3c272 GET /v1/drugs/ef921ef1-53c3-4a71-924a-e0ec77d3c272?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L01XX66"
],
"strength": null,
"pa_number": "EU/1/21/1537/001-004",
"substances": [
"Selinexor"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "26/03/2021",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about selinexor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.